Overview
Compare with Cannaisseur Group Inc., NEUTRA CORP. or NUTRA PHARMA CORP, or pick any stock.
- TickerAIBT on OTC1
- IndustryMedicinal Chemicals & Botanical Products1
- HeadquartersHeyburn, Idaho1
- Incorporated inNV2
- Business address480 22Nd Street, Heyburn, Id 833362
- Filer categoryNon-accelerated filer, Smaller reporting company2
See how the biggest companies compare on our leaderboards
The following description of our business contains forward-looking statements relating to future events or our future financial or operating performance that involve risks and uncertainties, as set forth above under “Special Note Regarding Forward-Looking Statements.” Our actual results could differ materially from those anticipated in these forward-looking statements as a result of certain factors described in the Annual Report, including those set forth above in the Special Cautionary Note Regarding Forward-Looking Statements or under the heading “Risk Factors” or elsewhere in this Annual Report.3 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Interest100¢$226.9K
Out of $2.2K in revenue.4 The company lost money this year.
Financial statements
Every line of the income statement as filed: the last 2 fiscal years, latest first.4
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Revenue | $2.2K | $0 |
| GROSS PROFIT | $2.2K | $0 |
| General and administrative | $1.8M | $1.6M |
| TOTAL OPERATING EXPENSES | $1.8M | $1.6M |
| NET LOSS FROM OPERATIONS | -$1.8M | -$1.6M |
| Interest expense | -$226.9K | -$213.5K |
| Loss on extinguishment of liabilities | -$144.2K | $0 |
| TOTAL OTHER EXPENSE | -$371.1K | -$213.5K |
| NET LOSS BEFORE PROVISION FOR INCOME TAXES | -$2.2M | -$1.8M |
| Provision for income taxes | $0 | $0 |
| NET LOSS | -$2.2M | -$1.8M |
| AVERAGE NUMBER OF COMMON SHARE OUTSTANDING - BASIC | -$0 | -$0 |
| AVERAGE NUMBER OF COMMON SHARE OUTSTANDING - DILUTED | -$0 | -$0 |
| AVERAGE NUMBER OF COMMON SHARE OUTSTANDING - BASIC AND DILUTED | 186.3M shares | 13.4M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.4
| Period ending | 2025-12-31 | 2024-12-31 | 2024-06-30 | 2023-12-31 |
|---|---|---|---|---|
| Cash | $255.9K | $185.1K | ||
| Prepaid expenses | $14.2K | $0 | ||
| TOTAL CURRENT ASSETS | $270.1K | $185.1K | ||
| Intangible assets, net | $604.6K | $1.3M | ||
| TOTAL ASSETS | $874.7K | $1.5M | ||
| Accounts payable and accrued expenses | $532.3K | $283.3K | ||
| Accrued expenses - related party | $807.0K | $864.0K | ||
| Accrued interest | $216.7K | $399.8K | ||
| Convertible note payable, net of debt discount | $1.1M | $1.1M | ||
| Note payable - related party | $165.0K | $165.0K | ||
| Shares to be issued | $2.0M | $2.0M | ||
| TOTAL LIABILITIES | $4.8M | $4.9M | ||
| TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' DEFICIT | $874.7K | $1.5M | ||
| Common stock, $0.001 par value, 7,500,000,000 467,000,000,shares authorized; 486,895,359 and 39,990,903, shares issued and outstanding, at December 31, 2025 and December 31, 2024, respectively | $486.9K | $40.0K | ||
| Additional paid-in capital | $8.6M | $7.4M | ||
| Accumulated deficit | -$13.0M | -$10.8M | ||
| TOTAL STOCKHOLDERS' DEFICIT | -$4.0M | -$3.4M | -$2.0M | |
| Preferred Stock, Shares Authorized | 5.0M shares | 5.0M shares | ||
| Common Stock, Par or Stated Value Per Share | $0.00 | $0.00 | ||
| Common Stock, Shares Authorized | 7.5B shares | 467.0M shares | 467.0M shares | |
| Common Stock, Shares, Issued | 486.9M shares | 40.0M shares | ||
| Common Stock, Shares, Outstanding | 486.9M shares | 40.0M shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2024-06-30 | 2023-12-31 |
|---|---|---|---|---|
| Cash | $255.9K | $185.1K | ||
| Prepaid expenses | $14.2K | $0 | ||
| TOTAL CURRENT ASSETS | $270.1K | $185.1K | ||
| Intangible assets, net | $604.6K | $1.3M | ||
| TOTAL ASSETS | $874.7K | $1.5M | ||
| Accounts payable and accrued expenses | $532.3K | $283.3K | ||
| Accrued expenses - related party | $807.0K | $864.0K | ||
| Accrued interest | $216.7K | $399.8K | ||
| Convertible note payable, net of debt discount | $1.1M | $1.1M | ||
| Note payable - related party | $165.0K | $165.0K | ||
| Shares to be issued | $2.0M | $2.0M | ||
| TOTAL LIABILITIES | $4.8M | $4.9M | ||
| TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' DEFICIT | $874.7K | $1.5M | ||
| Common stock, $0.001 par value, 7,500,000,000 467,000,000,shares authorized; 486,895,359 and 39,990,903, shares issued and outstanding, at December 31, 2025 and December 31, 2024, respectively | $486.9K | $40.0K | ||
| Additional paid-in capital | $8.6M | $7.4M | ||
| Accumulated deficit | -$13.0M | -$10.8M | ||
| TOTAL STOCKHOLDERS' DEFICIT | -$4.0M | -$3.4M | -$2.0M | |
| Preferred Stock, Shares Authorized | 5.0M shares | 5.0M shares | ||
| Common Stock, Par or Stated Value Per Share | $0.00 | $0.00 | ||
| Common Stock, Shares Authorized | 7.5B shares | 467.0M shares | 467.0M shares | |
| Common Stock, Shares, Issued | 486.9M shares | 40.0M shares | ||
| Common Stock, Shares, Outstanding | 486.9M shares | 40.0M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.4
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net loss | -$2.2M | -$1.8M |
| Depreciation expense | $0 | $498 |
| Amortization expense | $667.3K | $667.9K |
| Loss recognized on common stock issued to settle liability | $144.2K | $79.6K |
| Amortization of debt discount | $17.0K | $9.3K |
| Decrease in prepaid expense | $35.8K | $0 |
| Accounts payable and accrued expenses | $732.6K | $339.8K |
| Accrued interest | -$7.4K | $204.1K |
| Accrued expenses - related party | $168.0K | $288.0K |
| NET CASH USED IN OPERATING ACTIVITES | -$458.2K | -$259.0K |
| Proceeds from convertible note payable | $300.0K | $0 |
| Proceeds from the issuance of common stock | $279.1K | $0 |
| Proceeds from related party note payable | $0 | $165.0K |
| Repayments of convertible note payable | -$50.0K | $0 |
| NET CASH PROVIDED BY FINANCING ACTIVITES | $529.1K | $165.0K |
| NET CHANGE IN CASH | $70.8K | -$94.0K |
| Cash paid for interest | $0 | $0 |
| Cash paid for income taxes | $0 | $0 |
| Common stock issued to settle accounts payable and accrued expenses | $363.2K | $477.4K |
| Common stock issued to settle accrued expenses - related party | $225.0K | $0 |
| Common stock issued for cash and settlement of accrued interest, net of issuance costs | $876.9K | $0 |
| Issuance of common stock in exchange for consulting services | $50.0K | $0 |
| Shares to be issued | $44.0K | $44.0K |
| Exchange of common stock for Series A Preferred Stock | $0 | $9.8K |
| Issuance of Preferred Series B | $0 | $4.4K |
No quarter-by-quarter statement was filed.
What it owns
What AIBOTICS, INC. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Accumulated depreciation | $1.4M4 Dec 31, 2025 | $728.1K4 Dec 31, 2024 | +91.7% |
| Property and equipment, net | $09 Dec 31, 2024 | $4989 Dec 31, 2023 | −100.0% |
Properties, in its own words
2.1 · Stock Purchase Agreement between 20/20 Global, Inc. and Ehave, Inc. · Incorporated by reference from the Current Report on Form 8-K filed December 29, 2020
2.2 · Change of Control and Funding Agreement. · Incorporated by reference from the Current Report on Form 8-K filed December 29, 2020
The rest of Item 2
2.3 · Amendment to Escrow Agreement and Definitive Agreements. · Incorporated by reference from the Current Report on Form 8-K filed January 6, 2021
Item 2 of the 10-K filed Apr 15, 2026.3
Leadership
Who has led AIBOTICS, INC., and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
- Chief executive officerBenjamin Nathaniel Kaplan Jul 28, 2025 to now14
- Chief executive officerMark D. Williams Jun 18, 2019 to Aug 6, 202015
- PresidentMark D. Williams Jun 18, 2019 to Aug 6, 202015
- Chief financial officerMark D. Williams Aug 6, 2020 to Aug 6, 202016
Board members and other officers (5)
- Vice PresidentColin Gibson Jun 18, 2019 to Jun 18, 201917
- Board memberBenjamin Nathaniel Kaplan Jul 28, 2025 to now14
- Board memberMark Croskery Dec 17, 2024 to now18
- Board memberColin Gibson Jun 18, 2019 to Jun 18, 201917
- Board memberMark D. Williams Jun 18, 2019 to Aug 6, 202015
Former names
Timeline
- Oct 5, 20268-K Entered a material agreement19
- Jul 28, 2025New chief executive Benjamin Nathaniel Kaplan becomes CEO14
- Mar 24, 20258-K Entered a material agreement20
- Aug 21, 20248-K Entered a material agreement; Bylaws or fiscal year changed21
- Mar 28, 20248-K Change of auditor22
- Dec 5, 20238-K Entered a material agreement; Completed an acquisition or sale; Unregistered sale of shares23
- May 3, 20238-K Earlier financial statements no longer reliable24
- Feb 22, 20238-K Ended a material agreement; Regulation FD disclosure25
- May 19, 20228-K Entered a material agreement; Regulation FD disclosure26
- Jan 14, 20228-K Entered a material agreement27
- Jun 18, 2019New chief executive Mark D. Williams becomes CEO15
Filings
72 filings to the SEC since October 2021: 7 annual reports, 18 quarterly reports, 9 major events, 3 insider forms, 35 other. The latest 20:
- Oct 5, 20268-K AIBOTICS, INC. - FORM 8-K SEC FILING EDGAR
- Aug 19, 202610-Q AIBOTICS, INC. - FORM 10-Q SEC FILING EDGAR
- Aug 14, 2026NT 10-Q FORM NT 10-Q FILING EDGAR
- Jun 9, 202610-Q AIBOTICS, INC. - FORM 10-Q SEC FILING EDGAR
- May 15, 2026NT 10-Q FORM NT 10-Q FILING EDGAR
- Apr 15, 202610-K AIBOTICS, INC. - FORM 10-K SEC FILING EDGAR
- Mar 31, 2026NT 10-K AIBOTICS, INC.- NT10K EDGAR
- Jan 28, 2026S-8 AIBOTICS INC. - FORM S-8 FILING EDGAR
- Nov 19, 202510-Q AIBOTICS, INC. - FORM 10-Q SEC FILING EDGAR
- Nov 14, 2025NT 10-Q FORM NT 10-Q FILING EDGAR
- Aug 19, 202510-Q AIBOTICS, INC. - FORM 10-Q SEC FILING EDGAR
- Aug 14, 2025NT 10-Q FORM NT 10-Q FILING EDGAR
- Jul 28, 20254 PRIMARY DOCUMENT EDGAR
- Jul 3, 2025253G2 AIBOTICS FORM 253(G)(2) EDGAR
- Jul 1, 2025QUALIF EDGAR
- Jun 27, 2025CORRESP EDGAR
- Jun 27, 20251-A/A EDGAR
- Jun 24, 2025CORRESP EDGAR
- Jun 2, 20251-A/A EDGAR
- May 29, 2025CORRESP EDGAR
The 72 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
SEC filer profile
How AIBOTICS, INC. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARAIBOTICS, INC.1
- CIK0001763329
- Employer ID (EIN)87-06457943
- Filer statusNon-accelerated filer not an emerging growth company; a smaller reporting company; not a shell company3
- Incorporated inNevada3
- Fiscal year endsDecember 311
- Industry code (SIC)2833 Medicinal Chemicals & Botanical Products1
- SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
- Business address480 22Nd Street, Heyburn, ID 833361
- Phone208-677-20201
- Shares outstanding850,165,334 as of Aug 19, 202612
- Public float$1.4M as of 3
- AuditorFruci & Associates II, PLLC, Spokane, Washington PCAOB ID 55253
- On EDGAR sinceJan 31, 20191
- Filings108 in all: 10-Q (22), 8-K (15), NT 10-Q (15), 10-K (7), UPLOAD (7), NT 10-K (6), CORRESP (5), 1-A/A (4)1
All 23 form types
4 (4), 10-Q/A (3), 1-A (2), 10-12G (2), 10-12G/A (2), 10-K/A (2), 3 (2), QUALIF (2), S-8 (2), 253G2 (1), 8-K/A (1), DEF 14C (1), PRE 14C (1), RW (1), SC 14F1 (1)
- Latest filingsAnnual report (10-K) Apr 15, 2026
Quarterly report (10-Q) Aug 19, 2026
Latest 8-K (8-K) Oct 5, 2026
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARAIBOTICS, INC. filings on SEC EDGAR
- 2SEC EDGARAIBOTICS, INC. filings on SEC EDGAR
- 3
- 4SEC EDGARAIBOTICS, INC. 10-K for fiscal 2025
- 5SEC EDGARAIBOTICS, INC. 10-K for fiscal 2019
- 6SEC EDGARAIBOTICS, INC. 10-K for fiscal 2020
- 7SEC EDGARAIBOTICS, INC. 10-K for fiscal 2021
- 8SEC EDGARAIBOTICS, INC. 10-K for fiscal 2022
- 9SEC EDGARAIBOTICS, INC. 10-K for fiscal 2023
- 10SEC EDGARAIBOTICS, INC. 10-K for fiscal 2019
- 11SEC EDGARAIBOTICS, INC. 10-Q for fiscal 2026
- 12SEC EDGARAIBOTICS, INC. 10-Q for fiscal 2026
- 13SEC EDGARAIBOTICS, INC. 10-K for fiscal 2019
- 14
- 15
- 16
- 17SEC EDGARColin Gibson, Vice President
- 18SEC EDGARMark Croskery, Board member
- 19SEC EDGAREntered a material agreement
- 20SEC EDGAREntered a material agreement
- 21
- 22SEC EDGARChange of auditor
- 23
- 24
- 25
- 26
- 27SEC EDGAREntered a material agreement